Clinical characteristics and epidemiological situation of dengue fever in Peru: A systematic review.
DOI:
https://doi.org/10.35434/rcmhnaaa.2024.171.2409Keywords:
Dengue Fever, Peru, Epidemiology, MortalityAbstract
Introduction: Dengue is currently a concern in our country. Therefore, the aim of this study is to describe in detail the clinical characteristics and epidemiological situation of dengue in Peru. Methodology: Studies reporting patients with dengue fever in different regions of our country were identified and qualitatively summarized. The protocol of this investigation was registered in the Prospective International Register of Systematic Reviews (PROSPERO) database under the number CRD42024513895. An advanced search was conducted until February 18, 2024, in six databases, including PubMed, Scopus, Embase, Web of Science, Virtual Health Library, and Scielo. Observational studies and case reports were included. The results of the included articles were presented in tables and graphs. Results: The search results identified 545 articles, of which, after a rigorous selection process based on established criteria, 17 published between 1993 and 2023 were included. These studies covered 10 regions of Peru and included a total of 2310 patients diagnosed with dengue. Of the total, 43.68% (n = 1009) were female and 37.14% (n = 858) were male. Among the manifestations most frequently reported by patients were malaise, fever, headache, arthralgia, myalgia, retroocular pain, back pain, and rash/exanthema. In terms of outcome, the vast majority of patients managed to recover, while an unfortunate 1.73% (n = 40) died. Conclusions: The results presented provide a comprehensive view of the epidemiology of dengue and its clinical features in our country. These findings underline the urgent need to implement effective prevention and control strategies for this disease.
Downloads
Metrics
References
Brady OJ, Hay SI. The Global Expansion of Dengue: How Aedes aegypti Mosquitoes Enabled the First Pandemic Arbovirus. Annu Rev Entomol. 2020;65:191-208. doi:10.1146/annurev-ento-011019-024918.
Nakase T, Giovanetti M, Obolski U, Lourenço J. Global transmission suitability maps for dengue virus transmitted by Aedes aegypti from 1981 to 2019. Sci Data. 2023;10(1):275. doi:10.1038/s41597-023-02170-7.
Murray NEA, Quam MB, Wilder-Smith A. Epidemiology of dengue: past, present and future prospects. Clin Epidemiol. 2013;5:299-309. doi:10.2147/CLEP.S34440.
Roy SK, Bhattacharjee S. Dengue virus: epidemiology, biology, and disease aetiology. Can J Microbiol. 2021;67(10):687-702. doi:10.1139/cjm-2020-0572.
Epidemiological Update - Increase in dengue cases in the Region of the Americas - 29 March 2024 - PAHO/WHO | Pan American Health Organization. 2024 Available online: https://www.paho.org/en/documents/epidemiological-update-increase-dengue-cases-region-americas-29-march-2024 (accessed on 1 April 2024).
Kalayanarooj S. Clinical Manifestations and Management of Dengue/DHF/DSS. Trop Med Health. 2011;39(4 Suppl):83-7. doi:10.2149/tmh.2011-S10.
León-Figueroa DA, Abanto-Urbano S, Olarte-Durand M, Nuñez-Lupaca JN, Barboza JJ, Bonilla-Aldana DK, et al. COVID-19 and dengue coinfection in Latin America: A systematic review. New Microbes New Infect. 2022;49:101041. doi:10.1016/j.nmni.2022.101041.
Dengue and severe dengue. 2024. Available online: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue (accessed on 24 February 2024).
Harris E. WHO: Concerning Spread of Dengue, Chikungunya in Latin America. JAMA. 2023;329(16):1341. doi:10.1001/jama.2023.5624.
Situación del dengue en el Perú [Internet]. CDC MINSA. [citado 30 de mayo de 2023]. Disponible en: https://www.dge.gob.pe/portalnuevo/informacion-publica/situacion-del-dengue-en-el-peru/
Vigilancia epidemiológica de las enfermedades metaxenicas [Internet]. CDC MINSA. [citado 24 de febrero de 2024]. Disponible en: https://www.dge.gob.pe/portalnuevo/vigilancia-epidemiologica/vigilancia-epidemiologica-de-las-enfermedades-metaxenicas/
Material de capacitación Arbovirosis [Internet]. CDC MINSA. [citado 24 de febrero de 2024]. Disponible en: https://www.dge.gob.pe/portalnuevo/salas-situacionales/enfermedades-transmisibles/dengue/material-de-capacitacion-arbovirosis/
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71.
Luque N, Cilloniz C, Pons MJ, Donaires F, Albornoz R, Mendocilla-Risco M, et al. Clinical-epidemiological characteristics of deaths due to dengue during an outbreak in northern Peru. Rev Peru Med Exp Salud Publica. 2023;40(1):67-72. doi:10.17843/rpmesp.2023.401.12148.
Ramírez-Orrego L, M. Rojas L, J. Campos C, Gutierrez C, M. Chenet S, Gonzales L, et al. Primer reporte de un brote de dengue en balsas, Amazonas, Perú, durante 2021 y 2022. Rev Fac Med Humana. 2023;23(3):28-34. doi:10.25176/rfmh.v23i3.5846.
Montalvo R, Diaz-Lazo A, Montalvo M, Ninahuanca C. Comparación clínica y laboratorial de la fiebre amarilla severa versus dengue grave en Perú. Bol Malariol Salud Ambient. 2022;62(5):976-83.
Hurtado-Alegre J, Carrasco-Lozano LE, Zavala-Portugal J, Quispe-Pari JF, Matos-Prado ED. Insuficiencia respiratoria y hemoptisis en paciente con dengue: Hemorragia alveolar difusa como presentación inusual de dengue grave. Rev Cuerpo Méd Hosp Nac Almanzor Aguinaga Asenjo. 2022;15(2):269-72. doi:10.35434/rcmhnaaa.2022.152.1114.
Durand S, Chavez C, Vidal C, Cervantes G, Cabezas C, Durand S, et al. Frecuencia elevada de casos de dengue grave durante la epidemia por el linaje II del DENV-2 americano/asiático en el Perú. An Fac Med. 2022;83(3):205-8. doi:10.15381/anales.v83i3.22285.
Reátegui A, Falcón N, Reátegui A, Falcón N. Características epidemiológicas y clínicas de las infecciones por dengue y zika durante el fenómeno de El Niño Costero de 2017 en Chincha, Perú. Rev Investig Vet Perú. 2021. doi:10.15381/rivep.v32i2.20005.
Ruiz Chang WB. Caracterización clínica de pacientes con dengue provenientes del Hospital Distrital Santa Isabel - El Porvenir y del Hospital Distrital Laredo - Laredo, referidos al Laboratorio de Referencia Regional de La Libertad, Perú - 2019. Arnaldoa. 2020;27(1):237-46. doi:10.22497/arnaldoa.271.27114.
Elson WH, Reiner RC, Siles C, Bazan I, Vilcarromero S, Riley-Powell AR, et al. Heterogeneity of Dengue Illness in Community-Based Prospective Study, Iquitos, Peru. Emerg Infect Dis. 2020;26(9):2077-86. doi:10.3201/eid2609.191472.
Schaber KL, Paz-Soldan VA, Morrison AC, Elson WHD, Rothman AL, Mores CN, et al. Dengue illness impacts daily human mobility patterns in Iquitos, Peru. PLoS Negl Trop Dis. 2019;13(9):e0007756. doi:10.1371/journal.pntd.0007756.
Palomares-Reyes C, Silva-Caso W, Del Valle LJ, Aguilar-Luis MA, Weilg C, Martins-Luna J, et al. Dengue diagnosis in an endemic area of Peru: Clinical characteristics and positive frequencies by RT-PCR and serology for NS1, IgM, and IgG. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2019;81:31-7. doi:10.1016/j.ijid.2019.01.022.
Tito Perales Carrasco JC, Popuche Cabrera PL, Cabrejos Sampen G, Díaz-Vélez C, Tito Perales Carrasco JC, Popuche Cabrera PL, et al. Perfil clínico, epidemiológico y geográfico de casos de dengue durante el fenómeno El Niño Costero 2017, Lambayeque-Perú. Rev Habanera Cienc Médicas. 2019;18(1):97-113.
Rojas-Jaimes J, Ramos-Castillo J. Características de los exámenes de laboratorio en pacientes con dengue grave en un hospital de Puerto Maldonado - Perú. An Fac Med. julio de 2014;75(3):259-63. doi:10.15381/anales.v75i3.9782.
Silva Delgado H, Ruiz Ríos JC, Vela Barbarán EL, Rengifo del Aguila D, García M M, Rodríguez Benavides L, et al. Neonatal dengue in Peru: a case report. Rev Peru Med Exp Salud Publica. marzo de 2011;28(1):140-4.
Mamani E, Figueroa D, García MP, Garaycochea M del C, Pozo EJ. Infecciones concurrentes por dos serotipos del virus dengue durante un brote en el noroeste de Perú, 2008. Rev Peru Med Exp Salud Pública. 2010. doi:10.17843/rpmesp.2010.271.1439.
R JN, V CB, M MS. Caso de dengue hemorrágico en Iquitos. Rev Peru Med Exp Salud Pública. 2005 doi:10.17843/rpmesp.2005.223.998.
Mostorino E R, Rosas A Á, Gutiérrez P V, Anaya R E, Cobos M, García M M. Manifestaciones Clínicas y Distribución Geográfica de los Serotipos del Dengue en el Perú - Año 2001. Rev Peru Med Exp Salud Publica. 2002;19(4):171-80.
Phillips I, Need J, Escamilla J, Colán E, Sánchez S, Rodríguez M, et al. Primer brote de dengue documentado en la región amazónica del Perú. Bol Oficina Sanit Panam OSP1146jun 1993 [Internet]. 1993 [citado 23 de febrero de 2024]; Disponible en: https://iris.paho.org/handle/10665.2/16353
CDC. Centers for Disease Control and Prevention. 2021 [citado 24 de febrero de 2024]. Dengue Symptoms and Treatment| CDC. Disponible en: https://www.cdc.gov/dengue/symptoms/index.html
Khan MB, Yang ZS, Lin CY, Hsu MC, Urbina AN, Assavalapsakul W, et al. Dengue overview: An updated systemic review. J Infect Public Health. 2023;16(10):1625-42. doi:10.1016/j.jiph.2023.08.001.
Paraná VC, Feitosa CA, da Silva GCS, Gois LL, Santos LA. Risk factors associated with severe dengue in Latin America: A systematic review and meta-analysis. Trop Med Int Health TM IH. 2024. doi:10.1111/tmi.13968.
Chen LH, Marti C, Diaz Perez C, Jackson BM, Simon AM, Lu M. Epidemiology and burden of dengue fever in the United States: a systematic review. J Travel Med. 2023;30(7):taad127. doi:10.1093/jtm/taad127.
Kharwadkar S, Herath N. Clinical manifestations of dengue, Zika and chikungunya in the Pacific Islands: A systematic review and meta-analysis. Rev Med Virol. 2024;34(2):e2521. doi:10.1002/rmv.2521.
Moallemi S, Lloyd AR, Rodrigo C. Early biomarkers for prediction of severe manifestations of dengue fever: a systematic review and a meta-analysis. Sci Rep. 2023;13(1):17485. doi:10.1038/s41598-023-44559-9.
Htun TP, Xiong Z, Pang J. Clinical signs and symptoms associated with WHO severe dengue classification: a systematic review and meta-analysis. Emerg Microbes Infect. 2021;10(1):1116-28. doi:10.1080/22221751.2021.1935327.
Macêdo JVL, Frias IAM, Oliveira MDL, Zanghelini F, Andrade CAS. A systematic review and meta-analysis on the accuracy of rapid immunochromatographic tests for dengue diagnosis. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2022;41(9):1191-201. doi:10.1007/s10096-022-04485-6.
Sarkar S, Bora I, Gupta P, Sapkal G, Shethi S, Kaur K, et al. Utility of CDC DENV1-4 real time PCR assay and trioplex assay for the diagnosis of dengue in patients with acute febrile illness. Virusdisease. 2023;34(3):365-72. doi:10.1007/s13337-023-00831-0.
Rodriguez-Morales AJ, León-Figueroa DA, Sah R, Villamil-Gomez WE. Arboviral diseases and monkeypox – An epidemiological overlapping differential diagnosis? Rev Cuerpo Méd Hosp Nac Almanzor Aguinaga Asenjo. 2022;15(3):323-4. doi:10.35434/rcmhnaaa.2022.153.1678.
Chagas GCL, Rangel AR, Noronha LM, Veloso FCS, Kassar SB, Oliveira MJC, et al. Risk factors for mortality in patients with dengue: A systematic review and meta-analysis. Trop Med Int Health. 2022;27(8):656-68. doi:10.1111/tmi.13797.
Junior JBS, Massad E, Lobao-Neto A, Kastner R, Oliver L, Gallagher E. Epidemiology and costs of dengue in Brazil: a systematic literature review. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2022;122:521-8. doi:10.1016/j.ijid.2022.06.050.
Aguilar-Luis MA, Carrillo-Ng H, Kym S, Silva-Caso W, Verne E, Valle LJD, et al. Detection of Dengue Virus Serotype 3 in Cajamarca, Peru: Molecular Diagnosis and Clinical Characteristics. Int J Infect Dis. 2022;116:S119-20. doi:10.1016/j.ijid.2021.12.282.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Gina Carmela Ledesma Negreiros, Sandro Rodriguez Vásquez , Juan Víctor Valencia Hipólito
This work is licensed under a Creative Commons Attribution 4.0 International License.
